RFL vs RLYB

Rafael Holdings, Inc. vs Rallybio Corporation — Valuation Comparison 2026

RFL

Pharmaceutical Preparations
Rafael Holdings, Inc.
Quality
4.5
out of 10
Value Trap
66
DANGER
Price
$1.37
Last close
Models
10/13
Active
VS

RLYB

Pharmaceutical Preparations
Rallybio Corporation
Quality
5.4
out of 10
Value Trap
24
SAFE
Price
$14.46
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType RFL Fair ValueRFL Upside RLYB Fair ValueRLYB Upside
Bayesian DCF Intrinsic $0.50 -63.4% $8.09 -44.1%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.80 +31.1% $17.56 +21.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for RFL vs RLYB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RFL vs RLYB — Which Stock Is More Undervalued?

RLYB scores higher with a 5.4/10 quality rating vs RFL's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Rafael Holdings, Inc. (RFL) and Rallybio Corporation (RLYB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RFL currently trades at $1.37 with a QOC of 4.5/10, while RLYB trades at $14.46 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).